Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus

Background Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen ac...

Full description

Bibliographic Details
Main Authors: Ebtessam Zakaria, Maha Hossam Al-Din, Nashwa S Ghanem, Noha A Sadik, Maha Assem, Fatma Taha
Format: Article
Language:English
Published: SpringerOpen 2015-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=Zakaria
id doaj-d5c264da54dd4136a48c00cdfcc9838b
record_format Article
spelling doaj-d5c264da54dd4136a48c00cdfcc9838b2020-11-25T04:06:07ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982015-01-0127310811410.4103/1110-7782.165450Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitusEbtessam ZakariaMaha Hossam Al-DinNashwa S GhanemNoha A SadikMaha AssemFatma TahaBackground Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen activator (t-PA) with urinary albumin excretion (UAE) and renal disease progression in type 2 diabetes. Patients and methods A total of 50 patients with type 2 diabetes and 10 healthy control individuals were included in the study. Participants were subdivided according to UAE. Group 1 (G1) represented control individuals. Group 2 (G2) included patients without albuminuria. Group 3 (G3) included patients with microalbuminuria. Group 4 (G4) included patients with macroalbuminuria. Creatinine clearance and UAE were calculated. PAI-1 and t-PA were measured using an enzyme-linked immunosorbent assay kit, and the PAI-1/t-PA ratio was calculated as an index of impaired fibrinolysis. Results PAI-1 was highly elevated significantly in G4 when compared with the other groups, with a mean of 87.40 ± 17.03 IU/ml against 28.00 ± 6.98 IU/ml in G1, 46.4 ± 7.99 IU/ml in G2, and 64.10 ± 18.26 IU/ml in G3 (P < 0.001). Also, the serum level of t-PA in G4 was highly elevated significantly when compared with G1 and G2 with means of 16.85 ± 5.63 IU/ml against 7.95 ± 1.91 IU/ml and 10.45 ± 2.63 IU/ml, respectively (P < 0.001). The ratio of PAI-1/t-PA in G4 was significantly higher when compared with G1 (mean of 5.94 ± 2.81 against 3.54 ± 0.43; P = 0.01). PAI-1 and t-PA showed a significant positive correlation with UAE. Receiver operating characteristics curve analysis revealed that only PAI-1 and t-PA were significant discriminated factors for microalbuminuria and macroalbuminuria (P < 0.001). Conclusion Serum levels of PAI-1 and t-PA and the PAI-1/t-PA ratio were significantly increased in diabetic patients with higher UAE. Impaired fibrinolysis and increased UAE were associated with renal disease progression.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=ZakariaDiabetic nephropathy, impaired fibrinolysis, urinary albumin excretion
collection DOAJ
language English
format Article
sources DOAJ
author Ebtessam Zakaria
Maha Hossam Al-Din
Nashwa S Ghanem
Noha A Sadik
Maha Assem
Fatma Taha
spellingShingle Ebtessam Zakaria
Maha Hossam Al-Din
Nashwa S Ghanem
Noha A Sadik
Maha Assem
Fatma Taha
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
The Egyptian Journal of Internal Medicine
Diabetic nephropathy, impaired fibrinolysis, urinary albumin excretion
author_facet Ebtessam Zakaria
Maha Hossam Al-Din
Nashwa S Ghanem
Noha A Sadik
Maha Assem
Fatma Taha
author_sort Ebtessam Zakaria
title Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
title_short Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
title_full Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
title_fullStr Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
title_full_unstemmed Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
title_sort urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
publisher SpringerOpen
series The Egyptian Journal of Internal Medicine
issn 1110-7782
2090-9098
publishDate 2015-01-01
description Background Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen activator (t-PA) with urinary albumin excretion (UAE) and renal disease progression in type 2 diabetes. Patients and methods A total of 50 patients with type 2 diabetes and 10 healthy control individuals were included in the study. Participants were subdivided according to UAE. Group 1 (G1) represented control individuals. Group 2 (G2) included patients without albuminuria. Group 3 (G3) included patients with microalbuminuria. Group 4 (G4) included patients with macroalbuminuria. Creatinine clearance and UAE were calculated. PAI-1 and t-PA were measured using an enzyme-linked immunosorbent assay kit, and the PAI-1/t-PA ratio was calculated as an index of impaired fibrinolysis. Results PAI-1 was highly elevated significantly in G4 when compared with the other groups, with a mean of 87.40 ± 17.03 IU/ml against 28.00 ± 6.98 IU/ml in G1, 46.4 ± 7.99 IU/ml in G2, and 64.10 ± 18.26 IU/ml in G3 (P < 0.001). Also, the serum level of t-PA in G4 was highly elevated significantly when compared with G1 and G2 with means of 16.85 ± 5.63 IU/ml against 7.95 ± 1.91 IU/ml and 10.45 ± 2.63 IU/ml, respectively (P < 0.001). The ratio of PAI-1/t-PA in G4 was significantly higher when compared with G1 (mean of 5.94 ± 2.81 against 3.54 ± 0.43; P = 0.01). PAI-1 and t-PA showed a significant positive correlation with UAE. Receiver operating characteristics curve analysis revealed that only PAI-1 and t-PA were significant discriminated factors for microalbuminuria and macroalbuminuria (P < 0.001). Conclusion Serum levels of PAI-1 and t-PA and the PAI-1/t-PA ratio were significantly increased in diabetic patients with higher UAE. Impaired fibrinolysis and increased UAE were associated with renal disease progression.
topic Diabetic nephropathy, impaired fibrinolysis, urinary albumin excretion
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=Zakaria
work_keys_str_mv AT ebtessamzakaria urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
AT mahahossamaldin urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
AT nashwasghanem urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
AT nohaasadik urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
AT mahaassem urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
AT fatmataha urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus
_version_ 1724432377856393216